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PURPOSE: To report our initial experiences with laparoscopic partial cystectomy for urachal and bladder malignancy. 
MATERIALS AND METHODS: Between March 2002 and October 2004, laparoscopic partial cystectomy was performed in 6 
cases at 3 institutions; 3 cases were urachal adenocarcinomas and the remaining 3 cases were bladder transitional cell carcinomas. 
All patients were male, with a median age of 55 years (45-72 years). Gross hematuria was the presenting symptom in all patients, 
and diagnosis was established with trans-urethral resection bladder tumor in 2 patients and by means of cystoscopic biopsy in the 
remaining 4 patients. Laparoscopic partial cystectomy was performed using the transperitoneal approach under cystoscopic guid-
ance. In each case, the surgical specimen was removed intact entrapped in an impermeable bag. One patient with para-ureteral 
diverticulum transitional cell carcinoma required concomitant ureteral reimplantation. 
RESULTS: All six procedures were completed laparoscopically without open conversion. The median operating time was 110 min-
utes (90-220) with a median estimated blood loss of 70 mL (50-100). Frozen section evaluations of bladder margins were routinely 
obtained and were negative for cancer in all cases. The median hospital stay was 2.5 days (2-4) and the duration of catheterization 
was 7 days. There were no intraoperative or postoperative complications. Final histopathology confirmed urachal adenocarcinoma 
in 3 cases and bladder transitional cell carcinoma in 3 cases. At a median follow-up of 28.5 months (range: 26 to 44 months), there 
was no evidence of recurrent disease as evidenced by radiologic or cystoscopic evaluation. 
CONCLUSIONS: Laparoscopic partial cystectomy in carefully selected patients with urachal and bladder cancer is feasible and 
safe, offering a promising and minimally invasive alternative for these patients.
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INTRODUCTION
Partial cystectomy is indicated in specific cases of 
solitary dome/anterior wall bladder TCC, such as small 
unifocal tumors, solitary tumors in a bladder diverticulum, 
no concomitant carcinoma in situ (cis) or localized urachal 
adenocarcinoma. The goal of this surgical approach is to 
maintain a functional reservoir, while preserving continence 
and erectile function in male patients.1 In the case of 
these very specific tumors, the laparoscopic approach has 
the following advantages: a shorter recovery time and 
reduced length of hospital stay as compared with the open 
surgery approach. While laparoscopic partial cystectomy 
(LPC) has been performed for benign tumors, such as 
pheochromocytoma and bladder leyomyoma, data for its use 
in malignant disease is still lacking. Accordingly, this paper 
reports 6 cases of laparoscopic partial cystectomy for bladder 
or urachal malignancy performed at 3 institutions. 
MATERIALS AND METHODS
Between March 2002 and October 2004, 6 male patients 
underwent LPC for bladder cancer (n=3) or urachal cancer 
(n=3). The median age was 55.5 years (45-72). In all cases, 
the tumors were detected during clinical evaluation for gross 
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hematuria. The 3D-CT scan demonstrated a solitary, small 
(< 3cm) bladder mass on the dome with normal preserved 
perivesical fat planes and normal upper tracts in all patients 
but one patient. This subject had a superficial grade 2 TCC 
in a para-ureteral diverticulum that was not amenable to 
transurethral resection. In three patients, the urinary cytology 
was positive for neoplasic cells. The pathologic diagnosis 
was confirmed by TURBT or by means of cystoscopic 
biopsy, and concomitant cis was ruled out.
All procedures were performed using a 5-port transperitoneal 
approach similar to that used during standard laparoscopic 
radical cystectomy.2 The camera port was positioned at least 3 
cm above the umbilicus to facilitate adequate mobilization of the 
urachal remnant. The initial peritoneal incision was in the form 
of an “inverted V” with the limbs of the “V” positioned laterally 
to each medial umbilical ligament. The urachus and peritoneum 
along with the surrounding pre-peritoneal fat were widely 
mobilized en bloc. Once the dissection proceeded caudally 
into Retzius’ space, the tumor at the dome was typically 
visualized. At this point, the bladder was completely mobilized. 
The cystotomy began at a distance of 2 cm from the tumor 
under simultaneous cystoscopic guidance and was connected 
circumferentially leaving an adequate margin (2 cm) around 
the tumor. The tumor was resected en bloc together with the 
urachus and posterior rectus sheath. The surgical specimen was 
immediately placed into an EndoCatch® bag (USCC, Norwalk, 
CT) that was pre-positioned in the peritoneal cavity prior to 
creating the cystotomy. Bladder margins were sent for frozen 
section analysis. The bladder was then closed in two layers with 
a 2-0 Vicryl suture on a CT-1 needle and was filled with saline 
to identify areas of leakage that were subsequently reinforced 
with interrupted sutures. The retrieval bag was removed through 
an extension of the camera trocar site, and a Jackson Pratt drain 
was positioned in the prevesical space. The 10 and 12 mm port 
sites were closed using a Carter-Thomason port closure device 
with a 0 Vicryl suture. In the case of the patient who presented 
with a tumor in a para-ureteral diverticulum, a wide anterior 
cystotomy was initially created to clearly identify the opening 
of the diverticulum and the ureteral orifice. A wide bladder 
cuff was fashioned to include an adequate margin around the 
diverticular neck and the adjacent ureteral orifice. The bladder 
diverticulum containing the tumor and the distal ureter were 
excised by a combined intra- and extra-vesical approach. Real-
time transrectal ultrasound guidance was utilized to guide this 
difficult surgical excision. The defect in the bladder base was 
closed with 2-0 Vicryl sutures. The ureter was reimplanted 
in the dome extravesically in a refluxing manner. Finally, the 
anterior cystotomy was closed using a single layer of running 
2-0 Vicryl sutures.
RESULTS
All laparoscopic procedures were performed successfully 
without the need for open conversion. In one case of a high 
grade TCC located in a para-ureteral diverticulum, tumor 
resection involved a wide excision of the diverticulum 
together with the ureteral orifice, thereby requiring ureteral 
reimplantation, which was performed laparoscopically. The 
median estimated blood loss was 70 mL (range: 50-100 
mL), the median operative time was 110 min (range: 90-220 
min), and no intraoperative complications were noted. The 
median hospital stay was 2.5 days (range: 2-4 days). The 
postoperative course was uneventful in all 6 patients. In all 
cases, the indwelling Foley catheter was removed on the 7th 
postoperative day after a cystogram confirmed no leakage.
Intraoperative frozen section bladder margins were 
separately evaluated and were found negative for cancer 
in all cases. The final histopathologic analysis confirmed 
three cases of urachal adenocarcinoma and three cases of 
bladder transitional cell carcinoma, one of which featured 
sarcomatoid differentiation (Table 1). All surgical margins 
were negative for neoplasic cells. At a median follow-up 
Table 1 - Perioperative and pathological data
Age (yrs) Operative Time 
(min)
EBL (mL) Hospital stay 
(days)
Pathology Grade Stage
Patient #1 57 90 50 2 Urachal 
Adenocarcinoma
Moderate II*
Patient #2 58 110 100 2 Urachal 
Adenocarcinoma
Moderate II*
Patient #3 72 100 60 4 TCC Low IIa**
Patient #4 47 180 70 3 TCC High Ic**
Patient #5 54 90 50 3 Urachal 
Adenocarcinoma
Moderate IIIa*
Patient #6 45 220 70 2 TCC High IIa**
* Urachal staging system by Sheldon et al.; ** AJCC staging system
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of 28.5 months (range: 26-44 months), all 6 patients were 
alive with intact sexual function and no signs of recurrent or 
metastatic disease on cystoscopic, cytological or radiologic 
follow-up.
DISCUSSION
The role of partial cystectomy in the treatment of 
bladder cancer is very limited. In the case of TCC, it may be 
considered in certain carefully selected patients who present 
with a solitary lesion located in the dome/anterior wall 
with no in situ carcinoma, or in those patients with tumors 
located in bladder diverticula.2 Historical data on open partial 
cystectomy under these scenarios suggests a 5-year cancer-
specific survival rate of 50-70%.1,3,4
Urachal carcinoma is a rare tumor, accounting for <1% 
of all bladder tumors. The predominant cell pathology is 
adenocarcinoma. The survival of these patients is usually 
poor, due to the fact that the condition is generally diagnosed 
at a very late stage. Once a negative margin is achieved, the 
outcome of urachal adenocarcinoma is strongly correlated 
with clinical stage, independent of the surgical procedure.5
Henly et al. published data on 30 patients who were 
initially treated by open partial cystectomy. No adverse effect 
on survival was reported as compared with patients who 
underwent radical cystectomy.6 In a recent report by Ashley 
et al. that followed 130 patients with urachal masses, two 
predictors for malignancy were found: age over 55 years and 
presence of hematuria. Of the 60 cases of malignancy that 
were surgically treated, no survival difference was identified 
that could be correlated with the surgical procedure (partial 
cystectomy vs. radical cystectomy). The 5-year cancer-
specific survival rate was 49%, with a local recurrence rate 
of 15%. Multivariate analysis revealed that surgical margins 
and tumor grade were independent predictors of mortality. 
7
Laparoscopic partial cystectomy was initially performed 
for vesical endometriosis and was subsequently expanded to 
include malignant conditions.8,9 Mariano et al described their 
experience with LPC for bladder TCC in 6 patients. No open 
conversion was required, and a mean operative time of 205 
min was reported, with an estimated blood loss of 200 mL, 
and an average hospital stay of 4 days. One patient in this 
study subsequently developed systemic disease.10
The bladder should be widely dissected laterally 
(and posteriorly when needed), preserving the surround 
perivesical fat together with the tumor. Identification of the 
exact location of the tumor may be difficult from outside 
of the bladder. If the tumor is not readily apparent from 
the laparoscopic view once the bladder is filled with saline, 
additional aids such as intraoperative cystoscopy should be 
utilized. Once the initial cystotomy is created, the tumor can 
be easily visualized from inside of the bladder. The use of 
intraoperative real-time transrectal ultrasound guidance was 
particularly helpful in the case of a patient whose tumor 
was lodged within a para-ureteral diverticulum. Before the 
cystotomy is created, the bladder should be completely 
deflated to minimize the risk of tumor spillage. 
Although lymphadenectomy and umbilectomy were not 
identified as predictors in the aforementioned study, other 
researchers have reached different conclusions. As such, 
the role of these approaches in the treatment of urachal 
adenocarcinoma is still unclear. In a study performed 
by Wadhwa et al. of 3 patients who underwent LPC and 
lymphadenectomy for urachal adenocarcinoma, a mean 
operative time of 180 min was reported, together with a 
mean blood loss of 150 mL. Bilateral lymphadenectomy 
added 65 min to the procedure. One complication was 
reported, but the mean hospital stay remained at 4 days. No 
local recurrence or systemic disease was observed at a mean 
follow-up interval of 6 months.11
Again, certain technical aspects of LPC for urachal 
carcinoma deserve special attention: an en-bloc resection 
containing the urachus, bladder dome and posterior rectus 
sheath should be made, mobilization of the bladder is very 
useful and is particularly helpful during closure, and a wide 
surgical margin is important. In our study, lymphadenectomy 
and umbilectomy were not performed due to the small 
tumor sizes and the absence of enlarged nodes on imaging. 
However, pelvic lymphadenectomy can be performed 
completely laparoscopically if oncologically indicated. 
Even though the follow-up was short-term in this study, our 
data suggest both technical efficiency and low morbidity. 
Accordingly, we propose that this approach be considered 
a therapeutic option when an organ-sparing procedure is 
desired. 
CONCLUSION
Our experience to date suggests that laparoscopic partial 
cystectomy as a means of treating carefully selected cases of 
bladder and urachal malignancy is feasible, efficient, and has 
a low morbidity when performed by surgeons with extensive 
prior experience with advanced laparoscopic procedures.
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